NO20003112L - Aryltiazolidinonderivater - Google Patents

Aryltiazolidinonderivater

Info

Publication number
NO20003112L
NO20003112L NO20003112A NO20003112A NO20003112L NO 20003112 L NO20003112 L NO 20003112L NO 20003112 A NO20003112 A NO 20003112A NO 20003112 A NO20003112 A NO 20003112A NO 20003112 L NO20003112 L NO 20003112L
Authority
NO
Norway
Prior art keywords
aryltiazolidinonderivater
pparα
thiazolidinediones
hypertriglyceridemia
ppar
Prior art date
Application number
NO20003112A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003112D0 (no
Inventor
Soumya P Sahoo
Richard L Tolman
Wei Han
Jeffrey Bergmann
Conrad Santini
Vicki R Lombardo
Ranjit Desai
Julia K Boueres
Dominick F Gratale
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9816279.5A external-priority patent/GB9816279D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO20003112D0 publication Critical patent/NO20003112D0/no
Publication of NO20003112L publication Critical patent/NO20003112L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20003112A 1997-12-19 2000-06-16 Aryltiazolidinonderivater NO20003112L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6827197P 1997-12-19 1997-12-19
GBGB9816279.5A GB9816279D0 (en) 1998-07-27 1998-07-27 Arylthiazolidinedione derivatives
US10523898P 1998-10-22 1998-10-22
PCT/US1998/027139 WO1999032465A1 (fr) 1997-12-19 1998-12-18 Derives d'arylthiazolidinedione

Publications (2)

Publication Number Publication Date
NO20003112D0 NO20003112D0 (no) 2000-06-16
NO20003112L true NO20003112L (no) 2000-08-18

Family

ID=27269416

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003112A NO20003112L (no) 1997-12-19 2000-06-16 Aryltiazolidinonderivater

Country Status (21)

Country Link
EP (1) EP1040102B1 (fr)
JP (1) JP3373198B2 (fr)
KR (1) KR20010033355A (fr)
CN (1) CN1282325A (fr)
AT (1) ATE352545T1 (fr)
AU (1) AU740733B2 (fr)
BG (1) BG104602A (fr)
BR (1) BR9813801A (fr)
CA (1) CA2315397C (fr)
DE (1) DE69836980T2 (fr)
EA (1) EA200000687A1 (fr)
ES (1) ES2281146T3 (fr)
HU (1) HUP0101366A2 (fr)
ID (1) ID24878A (fr)
IL (1) IL136138A0 (fr)
IS (1) IS5506A (fr)
NO (1) NO20003112L (fr)
PL (1) PL340958A1 (fr)
SK (1) SK9212000A3 (fr)
TR (1) TR200001753T2 (fr)
WO (1) WO1999032465A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824614D0 (en) * 1998-11-11 1999-01-06 Glaxo Group Ltd Chemical compounds
EP1053989B1 (fr) * 1999-05-20 2007-07-25 Ciba SC Holding AG Composés hydroxyles d'éther diphénylique
EP1194146B1 (fr) * 1999-06-18 2006-07-19 Merck & Co., Inc. Derives d'arylthiazolidinedione et d'aryloxazolidinedione
AU5876900A (en) * 1999-06-18 2001-01-09 Merck & Co., Inc. Process for making arylthiazolidinedione derivatives
US7041691B1 (en) 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
WO2001016120A1 (fr) 1999-08-27 2001-03-08 Eli Lilly And Company Derives de biaryl-oxa(thia)zole et leur utilisation en tant que modulateurs de ppar
AU1303301A (en) * 1999-11-10 2001-06-06 Takeda Chemical Industries Ltd. Body weight gain inhibitors
US20030171399A1 (en) 2000-06-28 2003-09-11 Tularik Inc. Quinolinyl and benzothiazolyl modulators
AU2001298065A1 (en) * 2001-01-12 2003-09-02 Abbott Laboratories Process for the preparation of matrix metalloproteinase inhibitors
WO2002087580A1 (fr) * 2001-04-25 2002-11-07 Takeda Chemical Industries, Ltd. Promoteurs d'expression d'abc
AU2003256655A1 (en) * 2002-07-25 2004-02-16 Merck And Co., Inc. Therapeutic compounds for treating dyslipidemic conditions
ATE483699T1 (de) * 2002-08-30 2010-10-15 Hoffmann La Roche Neue 2-arylthiazolverbindungen als ppar-alpha und gamma agonisten
DK1567493T3 (da) * 2002-11-26 2009-06-08 Pfizer Prod Inc Phenyl-substituerede piperidin-forbindelser til anvendelse som PPAR-aktivatorer
CN1319956C (zh) * 2003-09-12 2007-06-06 深圳市海粤门生物科技开发有限公司 一种噻唑烷二酮的衍生物及其药用制剂的制备方法和应用
UA87467C2 (xx) * 2003-09-19 2009-07-27 Янссен Фармацевтика Н.В 4-((феноксіалкіл)тіо)феноксіоцтова кислота та її аналоги$4-((феноксиалкил)тио)феноксиуксусная кислота и ее аналоги
CA2539403C (fr) * 2003-09-19 2013-11-19 Janssen Pharmaceutica N.V. Acides 4-((phenoxyalkyl)thio)-phenoxyacetiques et analogues
DE602005001265T2 (de) * 2004-01-20 2008-01-31 Merck & Co., Inc. Antidiabetische oxazolidindione und thiazolidindione
WO2006138328A1 (fr) * 2005-06-14 2006-12-28 Merck & Co., Inc. Procede de production d'oxazolidinediones anti-diabetiques
CA2612765A1 (fr) * 2005-07-06 2007-01-18 Merck And Co., Inc. Oxazolidinediones et thiazolidinediones antidiabetiques
JP2009502783A (ja) * 2005-07-20 2009-01-29 メルク エンド カムパニー インコーポレーテッド 抗糖尿病性オキサゾリジンジオン及びチアゾリジンジオン
ES2569660T3 (es) 2007-06-08 2016-05-12 Mannkind Corporation Inhibidores de la IRE-1alfa
CN105001174A (zh) * 2015-07-14 2015-10-28 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端腈基苄基类结构的化合物及其用途
CN104987314A (zh) * 2015-07-14 2015-10-21 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端硝基苄基类结构的化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3053490B2 (ja) * 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−２，４−ジオン誘導体とその塩及び製造法
JP3906935B2 (ja) * 1995-12-18 2007-04-18 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
CA2245524A1 (fr) * 1996-02-02 1997-08-07 Wei Han Agents antidiabetiques
JP2002503202A (ja) * 1996-02-02 2002-01-29 メルク エンド カンパニー インコーポレーテッド 抗糖尿病薬
ATE236137T1 (de) * 1996-02-02 2003-04-15 Merck & Co Inc Heterocyclische verbindungen als antidiabetische mittel und für die behandlung von fettleibigkeit
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JP3373198B2 (ja) 2003-02-04
ID24878A (id) 2000-08-31
EA200000687A1 (ru) 2000-12-25
DE69836980T2 (de) 2007-11-15
EP1040102B1 (fr) 2007-01-24
IL136138A0 (en) 2001-05-20
CA2315397A1 (fr) 1999-07-01
ATE352545T1 (de) 2007-02-15
PL340958A1 (en) 2001-03-12
NO20003112D0 (no) 2000-06-16
JP2001526278A (ja) 2001-12-18
BR9813801A (pt) 2000-10-03
BG104602A (bg) 2001-01-31
DE69836980D1 (de) 2007-03-15
ES2281146T3 (es) 2007-09-16
CN1282325A (zh) 2001-01-31
AU1833499A (en) 1999-07-12
HUP0101366A2 (hu) 2001-09-28
IS5506A (is) 2000-05-23
WO1999032465A1 (fr) 1999-07-01
TR200001753T2 (tr) 2000-11-21
SK9212000A3 (en) 2001-02-12
AU740733B2 (en) 2001-11-15
EP1040102A4 (fr) 2002-11-27
CA2315397C (fr) 2007-08-07
EP1040102A1 (fr) 2000-10-04
KR20010033355A (ko) 2001-04-25

Similar Documents

Publication Publication Date Title
NO20003112D0 (no) Arylthiazolidindionderivater
ATE333448T1 (de) Arylthiazolidinedione und aryloxa zolidinedion- derivate
AU7705601A (en) N-substituted indoles useful in the treatment of diabetes
WO2002060434A3 (fr) Derives d'acide benzopyranocarboxylique pour traiter le diabete et d'autres troubles lipidiques
PL352367A1 (en) Glucagon antagonists/inverse agonists
IS5194A (is) Notkun þíasólídíndíonafleiða við meðferð á fjölblöðrueggjastokkaheilkennum og þungunarsykursýki
DK0546076T3 (da) Anvendelse af anti-ICAM antistoffer til fremstilling af et lægemiddel til behandling af endotoksiskshock
ATE242179T1 (de) Verfahren und vorrichtung zum homogenen erwärmen von gläsern und/oder glaskeramiken mit hilfe von infrarot-strahlung
FI901949A7 (fi) Happoa kestävä FGF-koostumus ja menetelmä ruuansulatuskanavassa esiint yvien, haavaumia aiheuttavien sairauksien hoitamiseksi
NO20073146L (no) 4-cykloalkyl-substituerte tetrahydrokinolinderivater og deres anvendelse som medikamenter
AUPM835394A0 (en) Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
IL121203A0 (en) Hypoglycemic and hypolipidemic compounds
ECSP993022A (es) Derivados de ariltiazolidindiona
DK0751775T3 (da) Hypocholesterolæmiske, antiatherosclerotiske og hypotriglyceridæmiske mercaptoacetylamidderivater
DK0458892T3 (da) Anvendelse af chlormethiazol ved fremstillingen af et medikament til forebyggelsen og/eller behandlingen af neurodegeneration
AR018898A1 (es) Derivados de 5-aril-2,4-tiazolidindiona, una composicion farmaceutica que los comprende y el uso de los mismos para la fabricacion de un medicamento
DK0463063T3 (da) Hængselforbundet lamineret genstand
FI963783A0 (fi) Hypokolesteroleemisiä, antiateroskleroottisia ja hypotriglyserideemisiä aminoasetyylimerkaptojohdannaisia
PT751774E (pt) Derivados de dissulfureto de mercaptoacetilamida hipocolesterolemicos
NO905292D0 (no) Fremgangsmaate for behandling av slam som oppstaar ved elektroplettering av metaller.
IT1225849B (it) Cerniera a profilo costante
RU95110558A (ru) Способ лечения инсулинзависимого сахарного диабета

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application